help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on September 25, 2002, doi:10.1164/rccm.200208-792OC

Am. J. Respir. Crit. Care Med., Volume 166, Number 10, November 2002, 1364-1368

A more recent version of this article appeared on November 15, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200208-792OCv1
166/10/1364    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Afessa, B.
Right arrow Articles by Peters, S. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Afessa, B.
Right arrow Articles by Peters, S. G

Submitted on August 5, 2002
Accepted on September 11, 2002

Outcome of Diffuse Alveolar Hemorrhage in Hematopoietic Stem Cell Transplant Recipients

Bekele Afessa1*, Ayalew Tefferi2, Mark R Litzow2, and Steve G Peters1

1 Department of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic and Foundation, Rochester, MN, USA, 2 Department of Medicine, Division of Hematology, Mayo Clinic and Foundation, Rochester, MN, USA

* To whom correspondence should be addressed. E-mail: afessa.bekele{at}mayo.edu.

Previous studies have reported mortality rates of about 80% in hematopoietic stem cell transplant recipients with diffuse alveolar hemorrhage. This retrospective study describes the clinical course of 48 such patients: Mean age 47.7 years, 52% autologous transplant, and 67% peripheral stem cell source. The hemorrhage occurred within one month of transplant in 28 patients. Symptoms included dyspnea in 92%, fever in 67%, cough in 56%, and hemoptysis in 15%. Intensive care unit admission was required in 85% and mechanical ventilation in 77%. Most of the patients were treated with intravenous methylprednisolone 1 g daily for three days and then tapered off after a median of 22 days. The hospital mortality was 48%. The cause of death was respiratory failure in 15 of the 23 deaths. Mortality was 28% in autologous compared to 70% in allogeneic transplant recipients (P = 0.0040). The mortality rate of patients whose hemorrhage occurred within the first 30 days of transplant was 32% compared to 70% of those with late hemorrhage (P = 0.0096). This study shows that survival rate of hematopoietic stem cell transplant recipients with diffuse alveolar hemorrhage is better than previously reported, and early onset and autologous transplant are favorable prognostic indicators.


Key words: respiratory insufficiency, bone marrow transplant, bronchoalveolar lavage, steroids




This article has been cited by other articles:


Home page
ChestHome page
A. Sachdeva and G. M. Matuschak
Diffuse Alveolar Hemorrhage Following Alemtuzumab
Chest, June 1, 2008; 133(6): 1476 - 1478.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Sharma, H. F. Nadrous, S. G. Peters, A. Tefferi, M. R. Litzow, M.-C. Aubry, and B. Afessa
Pulmonary Complications in Adult Blood and Marrow Transplant Recipients: Autopsy Findings
Chest, September 1, 2005; 128(3): 1385 - 1392.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
D Beckett and J Olliff
Non-infectious manifestations of stem cell transplantation
Br. J. Radiol., March 1, 2005; 78(927): 272 - 281.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. M. Kotloff, V. N. Ahya, and S. W. Crawford
Pulmonary Complications of Solid Organ and Hematopoietic Stem Cell Transplantation
Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 22 - 48.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. M. Pastores, E. Papadopoulos, L. Voigt, and N. A. Halpern
Diffuse Alveolar Hemorrhage After Allogeneic Hematopoietic Stem-Cell Transplantation: Treatment With Recombinant Factor VIIa
Chest, December 1, 2003; 124(6): 2400 - 2403.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. Azoulay, F. Fieux, D. Moreau, G. Thiery, P. Rousselot, A. Parrot, J.-R. Le Gall, H. Dombret, and B. Schlemmer
Acute Monocytic Leukemia Presenting as Acute Respiratory Failure
Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1329 - 1333.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Critical Care Medicine in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 294 - 305.
[Full Text] [PDF]


Home page
ImagingHome page
D F Q C Yu and S R Desai
Lung complications in patients undergoing bone marrow transplantation
Imaging, August 1, 2002; 14(4): 272 - 277.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society